Sarcoidosis MRI: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Sarcoidosis}} | {{Sarcoidosis}} | ||
{{CMG}} {{AE}} | {{CMG}} {{AE}}Roshan Dinparasti Saleh | ||
==Overview== | ==Overview== | ||
Currently, cardiac MRI([[CMR]]) is the technique of choice in diagnosis of subclinical or clinical [[cardiac sarcoidosis]]. It is fast, accurate, and noninvasive. | |||
==MRI== | ==MRI== | ||
T1-weighted MR shows : | |||
* [[wall motion abnormalities]] | |||
* Hypertrophy due to infiltration | |||
* Wall thinning | |||
* [[Heart failure]] | |||
* [[Late gadolinium enhancement]] (delayed enhancement) evaluates scar/[[fibrosis]] and can differentiate chronic versus active disease. Some studies also suggest that monitoring [[gadolinium]] enhancement may be helpful in the assessment of response to treatment with [[steroids]]<ref>Abrishami B, O'Connel C, Sharma O: Cardiac sarcoidosis with presentation of large left atrial mass. Current opinion in pulmonary medicine 2004, 10(5):397-400.</ref>Youssef G, Beanlands RS, Birnie DH, Nery PB: Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment. Heart (British Cardiac Society) 2011, 97(24):2078-2087.</ref><ref>Yeboah J, Lee C, Sharma OP: Cardiac sarcoidosis: a review 2011. Current opinion in pulmonary medicine 2011, 17(5):308-315.</ref>. | |||
==References== | ==References== | ||
Revision as of 16:11, 29 April 2018
|
Sarcoidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Sarcoidosis MRI On the Web |
|
American Roentgen Ray Society Images of Sarcoidosis MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Roshan Dinparasti Saleh
Overview
Currently, cardiac MRI(CMR) is the technique of choice in diagnosis of subclinical or clinical cardiac sarcoidosis. It is fast, accurate, and noninvasive.
MRI
T1-weighted MR shows :
- wall motion abnormalities
- Hypertrophy due to infiltration
- Wall thinning
- Heart failure
- Late gadolinium enhancement (delayed enhancement) evaluates scar/fibrosis and can differentiate chronic versus active disease. Some studies also suggest that monitoring gadolinium enhancement may be helpful in the assessment of response to treatment with steroids[1]Youssef G, Beanlands RS, Birnie DH, Nery PB: Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment. Heart (British Cardiac Society) 2011, 97(24):2078-2087.</ref>[2].